Breega — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Brink Therapeutics is a TechBio company developing programmable integrases, a nuclease-free platform for precise, large-payload genomic insertion of therapeutic genes for cell and gene therapy.
AI & Machine LearningBiotechDeep TechParis, FR
Jonathan Naccache(Co-founder (Directeur de la publication))in
Co-investorsKima VenturesKurma PartnersAgoranov
Alice & Bob develops quantum computing hardware based on cat-qubit technology, building superconducting quantum chips and cryogenic systems aimed at error-corrected quantum computation.
Deep TechHardwareQuantum Computing
Raphaël Lescanne(Founder)inThéau Peronnin(Founder)in
Co-investorsAgoranovATEL VenturesAtlantic Vantage PointC4 VenturesElaiaNVIDIA+4 more
Flow48 offers invoice financing and revenue-based financing that lets South African SMEs convert unpaid customer invoices into working capital, with funding typically disbursed within 24–48 hours and no collateral required.
FintechSaaS
Idriss Al Rifai(Founder)in
Co-investors212DaphniEvolution VenturesFirst Circle468 CapitalBlockchain Founders Fund+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















